Divarasib plus cetuximab in KRASG12C-positive colorectal cancer: a phase 1b trial – NATURE MEDICINE

Desai, J; Alonso, G; Kim, SH; Cervantes, A; Karasic, T; Medina, L; Shacham-Shmueli, E; Cosman, R; Falcon, A; Gore, E; Guren, T; Massarelli, E; Jr, WHM; Paz-Ares, L; Prenen, H; Amatu, A; Cremolini, C; Kim, TW; Moreno, V; Ou, SH; Passardi, A; Sacher, A; Santoro, A; Stec, R; Ulahannan, S; Arbour, K; Lorusso, P; Luo, J; Patel, MR; Choi, Y; Shi, Z; Mandlekar, S; Lin, MT; Royer-Joo, S; Chang, J; Jun, T; Dharia, N; Schutzman, JL; Han, SW – 2024 – 10.1038/s41591-023-02696-8